Tomoki Yamatsuji Selected Research

Tomoki Yamatsuji Research Topics

Disease

39	Neoplasms (Cancer) 07/2021 - 09/2003
15	Esophageal Neoplasms (Esophageal Cancer) 03/2013 - 10/2004
9	Neoplasm Metastasis (Metastasis) 05/2021 - 10/2004
6	Stomach Neoplasms (Stomach Cancer) 01/2022 - 09/2003
6	Carcinoma (Carcinomatosis) 07/2010 - 01/2004
5	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 02/2016 - 07/2011
4	Lung Neoplasms (Lung Cancer) 07/2015 - 11/2010
3	Lymphatic Metastasis 05/2021 - 10/2004
3	Hyperglycemia 01/2021 - 04/2007
3	Carcinogenesis 10/2010 - 01/2010
3	Gastrointestinal Stromal Tumors (Gastrointestinal Stromal Tumor) 11/2009 - 09/2005
2	Colorectal Neoplasms (Colorectal Cancer) 01/2016 - 07/2012
2	Renal Cell Carcinoma (Grawitz Tumor) 03/2013 - 07/2011
2	Colonic Neoplasms (Colon Cancer) 07/2012 - 09/2003
1	Residual Neoplasm 01/2022
1	Lymphoma (Lymphomas) 08/2021
1	Cecal Neoplasms 07/2021
1	Ileus 07/2021
1	Pathologic Constriction (Stenosis) 05/2021
1	Pancreatitis 01/2021
1	Sigmoid Neoplasms 01/2021
1	Dyslipidemias (Dyslipidemia) 01/2021
1	Hypertriglyceridemia 01/2021
1	Margins of Excision 10/2020
1	Malignant Mesothelioma 01/2020
1	Retroperitoneal liposarcoma 01/2019
1	Esophageal Squamous Cell Carcinoma 11/2017
1	Mycoses (Diseases, Fungus) 09/2013
1	Hypoxia (Hypoxemia) 03/2013
1	Weight Loss (Weight Reduction) 12/2012
1	Gastroesophageal Reflux (GERD) 12/2012
1	Injection Site Reaction 12/2011
1	Fever (Fevers) 12/2011
1	Melena 02/2011
1	Leiomyoma (Uterine Fibroids) 01/2011

Drug/Important Bio-Agent (IBA)

8	Proteins (Proteins, Gene)FDA Link 01/2013 - 01/2004
7	heparanaseIBA 07/2010 - 10/2004
5	Focal Adhesion Protein-Tyrosine KinasesIBA 07/2012 - 07/2008
4	TAE226IBA 07/2012 - 07/2008
3	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 07/2010 - 11/2005
2	AcidsIBA 08/2021 - 11/2010
2	Capecitabine (Xeloda)FDA Link 01/2021 - 01/2016
2	Transcription Factors (Transcription Factor)IBA 11/2017 - 10/2010
2	Oxaliplatin (Eloxatin)FDA LinkGeneric 01/2016 - 04/2009
2	Sirolimus (Rapamycin)FDA Link 03/2013 - 07/2011
2	temsirolimus FDA Link 03/2013 - 07/2011
2	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 01/2013 - 07/2008
2	5- (2,4- dihydroxy- 5- isopropylphenyl)- 4- (4- morpholin- 4- ylmethylphenyl)isoxazole- 3- carboxylic acid ethylamideIBA 01/2013 - 04/2012
2	Tyrosine Kinase InhibitorsIBA 07/2012 - 07/2008
2	Somatomedin Receptors (Somatomedin Receptor)IBA 07/2012 - 01/2010
2	isomaltulose (palatinose)IBA 03/2010 - 04/2007
2	Fluorouracil (Carac)FDA LinkGeneric 04/2009 - 09/2003
2	Imatinib Mesylate (Gleevec)FDA Link 01/2009 - 09/2005
2	Messenger RNA (mRNA)IBA 11/2005 - 10/2004
1	vasectrin I (VS I)IBA 01/2022
1	4-azidosalicylic acid-phosphatidylserineIBA 01/2022
1	PotassiumIBA 08/2021
1	SteroidsIBA 08/2021
1	Tumor Biomarkers (Tumor Markers)IBA 07/2021
1	Rosuvastatin Calcium (Crestor)FDA Link 01/2021
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2021
1	Pemetrexed (MTA)FDA Link 01/2020
1	RNA (Ribonucleic Acid)IBA 02/2016
1	mirdametinibIBA 07/2015
1	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 07/2015
1	polyglucosanIBA 09/2013
1	Fibrinogen (Factor I)FDA Link 03/2013
1	Pharmaceutical PreparationsIBA 03/2013
1	Molecular Chaperones (Chaperone, Molecular)IBA 01/2013
1	MidkineIBA 01/2013
1	Heparin (Liquaemin)FDA LinkGeneric 01/2013
1	Small Interfering RNA (siRNA)IBA 07/2012
1	Adenosine Triphosphate (ATP)IBA 07/2012
1	NVP-AEW541IBA 07/2012
1	AntibodiesIBA 07/2012
1	AntigensIBA 12/2011
1	Monatide (IMS 3015)IBA 12/2011
1	Peptides (Polypeptides)IBA 12/2011
1	PicibanilIBA 12/2011
1	VaccinesIBA 12/2011
1	Glutamine (L-Glutamine)FDA Link 02/2011
1	Androgen Receptors (Androgen Receptor)IBA 01/2011
1	Collagen Type IV (Type IV Collagen)IBA 01/2011
1	Surface-Active Agents (Surfactants)IBA 12/2010
1	CCAAT-Enhancer-Binding Protein-alphaIBA 12/2010
1	Pulmonary Surfactants (Pulmonary Surfactant)IBA 12/2010
1	Telomerase (Telomerase Reverse Transcriptase)IBA 12/2010
1	AmidesIBA 11/2010

Therapy/Procedure

16	Therapeutics 05/2015 - 01/2007
5	Esophagectomy 12/2012 - 10/2004
4	Drug Therapy (Chemotherapy) 05/2021 - 10/2004
4	Oral Administration 05/2015 - 07/2008
3	Lymph Node Excision (Lymph Node Dissection) 01/2022 - 05/2015
3	Gastrectomy 01/2022 - 10/2020
2	Adjuvant Chemotherapy 01/2016 - 05/2015
1	Colectomy 07/2021
1	Decompression 07/2021
1	Ileostomy 05/2021
1	Segmental Mastectomy (Lumpectomy) 01/2019
1	Metastasectomy 01/2019